Aldeyra Therapeutics to Host 2020 Research & Development Day
Live Webcast Scheduled to Begin at
The event will include presentations from members of the Aldeyra executive team and Paul Karpecki, O.D., FAAO. Dr. Karpecki is Clinical Director, Corneal Services and Advanced Ocular Surface Disease at
The presentations will focus on the company’s development plans and market opportunities for its novel product candidates in dry eye disease, allergic conjunctivitis, and proliferative vitreoretinopathy.
The presentations are scheduled to begin at Noon (ET)
A live audio webcast of the presentation and a slide deck will be available via the company's Investor Relations website at https://ir.aldeyra.com/. Following the live webcast, an archived version will be available on the website for 90 days.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20200211005323/en/
Source:
Corporate Contact:
David McMullin
Aldeyra Therapeutics, Inc.
Tel: 781-761-4904 ext. 218
dmcmullin@aldeyra.com
Investor & Media Contact:
Scott Solomon
Sharon Merrill Associates, Inc.
Tel: 617-542-5300
ALDX@investorrelations.com